Aphria Inc.’s U.S.-listed shares slid 9% Tuesday before paring their losses, after the Canadian cannabis company posted weaker-than-expected revenue for its second quarter and revised down its guidance to reflect issues including a slower rollout of retail locations in Ontario….
